Alpha-thalassemia in premature newborns

Area of Science:

• Genetics
• Hematology
• Neonatology

Background:

• Alpha-thalassemia is a common inherited blood disorder.
• Premature infants may present unique challenges for diagnosis and management.
• Understanding alpha-thalassemia in premature infants is crucial for early intervention.

Purpose of the Study:

• To determine the incidence and expression of alpha-thalassemia syndromes in Sardinian premature infants.
• To correlate alpha-globin genotype with phenotype in this specific population.
• To assess the hematological parameters in premature infants with different alpha-thalassemia genotypes.

Main Methods:

• Alpha-globin gene mapping
• Hemoglobin (Hb) Bart's quantitation
• Serum bilirubin measurement
• Red blood cell indices determination
• Study population: Sardinian premature infants (32-35 wk gestation)

Main Results:

• Gene frequencies for deletion (-alpha) and nondeletion (alpha alpha th) alpha-thalassemia were 0.29 and 0.04, similar to full-term newborns.
• Majority of premature infants with a single alpha-globin gene deletion [(-alpha/alpha alpha)] were hematologically silent.
• Infants with two alpha-globin gene deletions [(-alpha/-alpha)] exhibited moderate Hb Bart's (3.5-8.1%) and decreased Hb levels and red blood cell indices.
• One infant with three alpha-globin gene deletions developed Hb H disease with 25% Hb Bart's and microcytic anemia.
• Nondeletion alpha-thalassemia carriers showed variable Hb Bart's with thalassemia-like red cell indices.

Conclusions:

• Alpha-thalassemia gene frequencies in Sardinian premature infants are comparable to full-term newborns.
• The severity of alpha-thalassemia expression in premature infants is directly related to the number of alpha-globin gene deletions.
• Genotype-phenotype correlations are evident, with multiple deletions leading to significant hematological alterations and potential clinical manifestations like Hb H disease.